Key result
A structured pharmaceutical care program improved compliance, exercise capacity, and knowledge of drug therapy, and reduced hospital admissions compared with standard care over 12 months.
Why the study?
Does a structured pharmaceutical care program improve outcomes and reduce healthcare utilization in elderly patients with congestive heart failure?
Population
83 elderly patients (> 65 years) with congestive heart failure (CHF)
Comparison
Structured pharmaceutical care program including… vs Standard care
Design
RCT, randomized
Follow-up
12 months
Authors
Loading...
May support pharmaceutical care in elderly HF; hypothesis-generating, requiring RCT confirmation before practice change.
RCT (n=83)
No
Does a structured pharmaceutical care program improve outcomes and reduce healthcare utilization in elderly patients with congestive heart failure?
Varma et al. (1999) conducted an RCT in Congestive heart failure (n=83). Structured pharmaceutical care program vs. Standard care was evaluated on Disease control, quality of life, and use of health care facilities. A structured pharmaceutical care program improved compliance, exercise capacity, and knowledge of drug therapy, and reduced hospital admissions compared with standard care over 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: